Catalina Falo

4PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 11, 2025
Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial.

Andrea Vethencourt, Eva M Trinidad, Eduard Dorca

|Jan 16, 2023
Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness.

Héctor Pérez-Montero, Alicia Lozano, Rodolfo de Blas

Pageof 1